ValueQ4, 24Q4, 25TTMSelling/general/admin expenses———Research & development———Operating income-426.69 M-753.53 M-1.68 BNon-Operating Income, Total———Interest expense, net of interest capitalized———Non-Operating Income, excl. Interest Expenses———Unusual income/expense———Pretax income-426.69 M-753.53 M-1.68 BEquity in earnings———Taxes145.16 M8.96 M232.07 MNon-controlling/minority interest———After tax other income/expense———Net income before discontinued operations-571.85 M-762.49 M-1.91 BDiscontinued operations———Net income-571.85 M-762.49 M-1.91 BDilution adjustment———Preferred dividends———Diluted net income available to common stockholders-571.85 M-762.49 M-1.91 BBasic earnings per share (Basic EPS)———Diluted earnings per share (Diluted EPS)-6.89-9.66-23.54Average basic shares outstanding82.48 M78.42 M—Diluted shares outstanding83.03 M78.97 M—EBITDA———EBIT———Cost of revenue———Other cost of goods sold———Depreciation & amortization (cash flow)350.3 M227.2 M—
ICON plc - Ordinary Shares
Icon plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.